Wingate Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$18.4K 96
2024
Q4
$18.4K Buy
+1,000
New +$18.4K 0.02% 296